Chevy Chase Trust Holdings LLC lessened its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 4.2% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 287,001 shares of the financial services provider’s stock after selling 12,502 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in MetLife were worth $23,640,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also recently made changes to their positions in the company. Brighton Jones LLC boosted its stake in MetLife by 9.0% during the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after buying an additional 351 shares during the last quarter. Caxton Associates LLP bought a new stake in MetLife in the 1st quarter worth approximately $307,000. Empowered Funds LLC increased its stake in MetLife by 187.6% in the 1st quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider’s stock worth $2,680,000 after acquiring an additional 21,771 shares during the last quarter. Sivia Capital Partners LLC purchased a new stake in shares of MetLife during the 2nd quarter worth approximately $404,000. Finally, Foundations Investment Advisors LLC boosted its position in shares of MetLife by 16.7% during the 2nd quarter. Foundations Investment Advisors LLC now owns 3,885 shares of the financial services provider’s stock valued at $312,000 after acquiring an additional 555 shares during the last quarter. 94.99% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts recently weighed in on MET shares. UBS Group raised their target price on shares of MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Mizuho set a $100.00 price objective on shares of MetLife in a research report on Thursday, February 12th. TD Cowen dropped their price objective on shares of MetLife from $91.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, March 11th. Morgan Stanley reduced their target price on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Finally, Weiss Ratings cut shares of MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, March 9th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and an average target price of $93.67.
MetLife Stock Up 1.8%
Shares of MET opened at $69.21 on Tuesday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The business has a fifty day moving average of $75.95 and a 200 day moving average of $78.25. The company has a market cap of $45.13 billion, a PE ratio of 14.72, a P/E/G ratio of 0.61 and a beta of 0.76. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $85.00.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business had revenue of $52.44 billion for the quarter, compared to analysts’ expectations of $31.43 billion. During the same quarter in the previous year, the business posted $2.08 earnings per share. The business’s revenue was up 27.6% compared to the same quarter last year. On average, sell-side analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.
MetLife Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd were issued a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a yield of 3.3%. The ex-dividend date was Tuesday, February 3rd. MetLife’s dividend payout ratio is presently 48.30%.
MetLife Company Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
See Also
- Five stocks we like better than MetLife
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
